Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Johnson & Johnson (JNJ)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 360,769,568
  • Shares Outstanding, K 2,682,900
  • Annual Sales, $ 76,450 M
  • Annual Income, $ 1,300 M
  • 36-Month Beta 0.73
  • Price/Sales 4.65
  • Price/Cash Flow 13.86
  • Price/Book 5.65

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate 2.03
  • Number of Estimates 8
  • High Estimate 2.09
  • Low Estimate 2.00
  • Prior Year 1.90
  • Growth Rate Est. (year over year) +6.84%

Price Performance

See More
Period Period Low Period High Performance
1-Month
125.45 +9.10%
on 07/23/18
137.12 -0.19%
on 08/20/18
+11.01 (+8.75%)
since 07/20/18
3-Month
118.62 +15.38%
on 05/29/18
137.12 -0.19%
on 08/20/18
+12.62 (+10.16%)
since 05/18/18
52-Week
118.62 +15.38%
on 05/29/18
148.32 -7.73%
on 01/17/18
+4.23 (+3.19%)
since 08/18/17

Most Recent Stories

More News
5 Hot Stocks in the Dow ETF Last Week

Dow Jones closed at its highest level since February, We have highlighted the five best performing stocks of last week in its ETF.

AAPL : 215.39 (-1.01%)
CSCO : 46.23 (+0.78%)
VZ : 54.64 (-0.27%)
JNJ : 136.89 (+1.80%)
DIA : 257.43 (+0.36%)
WMT : 95.99 (-1.90%)
Johnson & Johnson to Host Investor Conference Call on the Pharmaceutical Business

Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:00 a.m. (Eastern Time) on Thursday, September 13th, to review its Pharmaceutical Business. Joaquin Duato, Vice Chairman of...

JNJ : 136.89 (+1.80%)
Johnson&Johnson (JNJ) Breaks Through Resistance at $135.58

Johnson&Johnson (NYSE:JNJ) has opened bullishly above the pivot of $133.89 today and has reached the first level of resistance at $135.58. Should the shares continue to rise, the resistance pivots of...

JNJ : 136.89 (+1.80%)
Electrophysiology Devices Market Growth Intensifies on Heels of Latest Technological Advancements

PALM BEACH, Florida, August 20, 2018 /PRNewswire/ --

ABT : 64.65 (-0.11%)
BSX : 34.57 (+0.46%)
JNJ : 136.89 (+1.80%)
BSGM : 2.5500 (-6.93%)
MDT : 90.04 (-0.62%)
BioSig Appoints Johnson & Johnson Veteran Amy Scott

BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology...

JNJ : 136.89 (+1.80%)
BSGM : 2.5500 (-6.93%)
5 Hot Stocks in the Dow ETF Last Week

Dow Jones closed at its highest level since February, We have highlighted the five best performing stocks of last week in its ETF.

AAPL : 215.39 (-1.01%)
CSCO : 46.23 (+0.78%)
VZ : 54.64 (-0.27%)
JNJ : 136.89 (+1.80%)
DIA : 257.43 (+0.36%)
WMT : 95.99 (-1.90%)
Pharma Stock Roundup: Blow for Bayer, FDA Nod for MRK Cancer Drug in New Indication

Bayer's (BAYRY) Monsanto subsidiary faces $289 million fine in Roundup lawsuit. Merck/Eisai's drug Lenvima gets FDA approval to treat the most common form of liver cancer.

BAYRY : 23.2800 (+2.42%)
AZN : 38.85 (+1.92%)
PTIE : 0.90 (-2.17%)
JNJ : 136.89 (+1.80%)
MRK : 70.17 (+1.61%)
LLY : 105.81 (+0.25%)
GSK : 41.32 (+0.17%)
Glaxo, J&J's Dual Drug HIV Regimen Succeeds in Phase III Study

Glaxo (GSK) and Johnson and Johnson report positive top line results from a late-stage study of their injectable two-drug regimen for the treatment of HIV.

JNJ : 136.89 (+1.80%)
GILD : 72.35 (-0.78%)
PFE : 42.33 (+0.57%)
GSK : 41.32 (+0.17%)
KFx Medical, LLC Inks 5th Knotless Double Row Patents License

KFx Medical, LLC announced that it has entered into a license agreement with Zimmer Biomet Holdings, Inc. (NYSE: ZBH) relating to KFx patents used in knotless double row rotator cuff repair....

WMGI : 27.51 (-0.11%)
ZBH : 124.65 (+0.64%)
SNN : 35.38 (-1.06%)
JNJ : 136.89 (+1.80%)
CNMD : 78.26 (+0.71%)
Why Is Johnson & Johnson (JNJ) Up 1% Since Its Last Earnings Report?

Johnson & Johnson (JNJ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

JNJ : 136.89 (+1.80%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Longer term, the trend strength is in the Top 1%. Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade JNJ with:

Business Summary

Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin...

See More

Key Turning Points

2nd Resistance Point 136.70
1st Resistance Point 135.58
Last Price 136.89
1st Support Level 132.77
2nd Support Level 131.08

See More

52-Week High 148.32
Fibonacci 61.8% 136.97
Last Price 136.89
Fibonacci 50% 133.47
Fibonacci 38.2% 129.97
52-Week Low 118.62

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar